about
Evaluation of Metoprolol Pharmacokinetics in Patients Receiving Hi Flux HemodialysisComparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial FibrillationComparison of Blood Pressure Medications on MetabolismFactorial Study of Metoprolol Succinate TOPROL-XL (324A)Effect of Beta Blocker Treatment on Endothelial Function in Patients With Type 2 Diabetes or Chronic Heart FailureSympathetic Nervous System Modulation in HypertensionComparison of Bisoprolol With Metoprolol Succinate Sustained-release on Heart Rate and Blood Pressure in Hypertensive PatientsComparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive PatientsEffects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive PatientsEffect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With NormoalbuminuriaAdjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart FailureA Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of HypertensionCardiovascular Effects of Selective I(f)-Channel BlockadeEfficacy and Safety of Metoprolol Succinate Prolonged-Release Tablet in Patients With Mild to Moderate HypertensionBEtablocker Treatment After Acute Myocardial Infarction in Patients Without Reduced Left Ventricular Systolic FunctionDanish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection FractionA Polypill for Secondary Prevention of Ischemic Heart DiseaseThe Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive PatientsCurative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to RevascularizationCurative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to RevascularizationRace, Natriuretic Peptides and Physiological PerturbationsMetoprolol in Acute Myocardial Infarction. A PK/PD StudyDrug Interaction Study of Pyronaridine-artesunate and Metoprolol and Pyronaridine-artesunate Re-dosing Study in Healthy VolunteersTo Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of MetoprololEnhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)The Impact of Nebivolol Versus Metoprolol on Quality of LifeCo-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)Heart Rate Variability (HRV) to Evaluate Surgical Risk on Patients on Beta BlockersEffect of METOprolol in CARDioproteCtioN During an Acute Myocardial InfarCtion. The METOCARD-CNIC Trial.Combined Antihypertensive Therapy and Sexual DysfunctionEfficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking AmlodipineTREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"Bariatric Surgery and Pharmacokinetics of MetoprololCoronary Atherosclerosis T1-Weighted Characterization (CATCH)Beta-blockers to Patients With Chronic Obstructive Pulmonary DiseaseA Study of the Effect of Epinephrine on Platelet Reactivity in Subjects Treated With TicagrelorA Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary SyndromeEfficacy and Safety of Sotalol in Children With Arrhythmia
P4844
Q61906721-41821450-A608-4299-98F3-182C0D04D864Q61909130-EA473AAA-3696-436C-93CB-9B9FCA280564Q61914730-DFBAECA5-1722-4074-AD3F-C6192EFDC4D0Q61914760-CB3FF05B-65CF-43F9-AF46-0D3D3B1B014DQ61917445-D201202C-0D55-42A7-BAE9-3E53A278C952Q61917972-E92E167A-93EC-4AB6-BDF6-A9CF4F110A39Q61956598-C1942EC2-948F-4769-815D-8E7F308A2FC5Q61957466-E9330539-C902-42C9-8AC9-8384FE135957Q61957545-A1D06F99-60B8-48A6-B0FB-9AC9D153470AQ61957704-89260B99-B405-43D4-8CA5-5B485674E14FQ61965860-E8C07DFD-F1F7-465D-B3EE-2EBD2FA9FE43Q61975354-36DECD99-4EF0-4A3D-9E2E-0961E4699597Q61975385-84DC6254-DEE1-41B4-8981-5A7906D20202Q61981029-CDC32F0F-9476-44D8-AD27-1222A621E293Q61981445-62C5E3AC-B40A-4E51-B7E7-F72946A6C15EQ62025756-23A6E452-23F7-4B90-BFB0-457ED6AAF87EQ62030656-0AD30355-3BC0-499B-92D0-58F7D807C605Q62811917-9EC809B0-5119-4F26-9278-D7FA86F9A26CQ62815558-767BFFD3-46D0-4E53-B0D9-89851DBFAB0FQ63062387-A1367D33-C3A8-40A3-B946-A6BE44745DE9Q63228969-45D83F08-48E5-45D6-AF52-60A3A40D910CQ63228972-AECC64CB-2AEA-497D-B9E0-F5D7F3C053FDQ63229120-C13461F5-4D16-41C0-91F8-8A62BF61D8EBQ63319680-20FB2EA6-8426-460E-8CD2-1F71EE004539Q63319693-B0C08F7D-D283-43AD-932A-97EDE1B18C28Q63320191-EC1CDFFA-994F-41F6-9A90-B63DF8F91B22Q63321857-25CCE66E-2772-442F-B0BE-C384975E7B0FQ63322309-55FC3901-06E6-46F6-8813-061B7C5E11C4Q63335554-AE408E47-7A10-47AD-A7AE-9F1EDE0BEE2DQ63337917-E734D03B-4234-4F61-BDCD-302B888F8EDCQ63339111-6D0306D1-4BDF-4535-96CA-C093DF45D78FQ63340456-BC7C58FD-A4AC-41F6-AE80-B5DB14BD7E7FQ63394281-9ACC6387-4CBF-4BAD-BBA7-F782666ABF0DQ63394539-2C3428FF-E2C8-4CC7-B393-142BE57383F3Q63397595-BCCA4D44-C11F-42C8-AEA1-D24E68AF407FQ63397893-956D8115-1A7B-4605-9F2A-FD172E06633EQ63398124-BBF21143-C6E5-4CD5-9808-10CE6F59912BQ63400969-18870D61-CAA5-4358-8F6C-ABFF92E61A47Q63401799-159128EE-67FE-404C-8383-814DFC42AE3CQ63580559-CCF26AAB-92E0-4394-8FD4-5CE626E9B024
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
metoprolol succinate
@en
type
label
metoprolol succinate
@en
prefLabel
metoprolol succinate
@en
P592
P661
P662
P683
P2067
P2115
N0000148377
P231
98418-47-4
P232
P233
CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(CC(=O)O)C(=O)O
P234
1S/2C15H25NO3.C4H6O4/c2*1-12(2 ...... 1H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
P235
RGHAZVBIOOEVQX-UHFFFAOYSA-N
P2566
100.149.317
P274
C₃₄H₅₆N₂O₁₀
P2892
P3117
DTXSID9048726
P3345
P592
CHEMBL2356097
P652
TH25PD4CCB